Alexander Craig • UCSF Profiles (original) (raw)

  1. Utility of PD-1, PD-L1, and IDO-1 Stains in Ocular Extranodal Marginal Zone Lymphoma (MZL) and Diffuse Large B-cell Lymphoma (DLBCL). Appl Immunohistochem Mol Morphol. 2024 Sep 01; 32(8):395-399. Craig A, Güney E, Pekmezci M, Bloomer M, Laszik Z, Ohgami RS, Toland A, Vogel H, Forns T, Wang E, Rubenstein J, Wen KW. PMID: 38899518.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  2. ALK+ ALCL in the setting of adalimumab-related hidradenitis suppurativa. Clin Case Rep. 2023 Apr; 11(4):e7156. Craig A, Wen KW. PMID: 37064740; PMCID: PMC10090933.
    View in: PubMed Mentions: 3
  3. A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL. Blood Adv. 2023 04 11; 7(7):1137-1145. Cherng HJ, Alig SK, Oki Y, Nastoupil LJ, Fayad L, Neelapu SS, Turturro F, Hagemeister F, Craig AFM, Macaulay CW, Rodriguez MA, Lee HJ, McDonnell TJ, Flowers CR, Vega F, Green MR, Feng L, Kurtz DM, Alizadeh AA, Davis RE, Westin JR. PMID: 36375046; PMCID: PMC10111343.
    View in: PubMed Mentions: 5 Fields:
    Translation:HumansCTClinical Trials
  4. Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. Cancer Cell. 2023 01 09; 41(1):210-225.e5. Sworder BJ, Kurtz DM, Alig SK, Frank MJ, Shukla N, Garofalo A, Macaulay CW, Shahrokh Esfahani M, Olsen MN, Hamilton J, Hosoya H, Hamilton M, Spiegel JY, Baird JH, Sugio T, Carleton M, Craig AFM, Younes SF, Sahaf B, Sheybani ND, Schroers-Martin JG, Liu CL, Oak JS, Jin MC, Beygi S, Hüttmann A, Hanoun C, Dührsen U, Westin JR, Khodadoust MS, Natkunam Y, Majzner RG, Mackall CL, Diehn M, Miklos DB, Alizadeh AA. PMID: 36584673; PMCID: PMC10010070.
    View in: PubMed Mentions: 71 Fields:
    Translation:HumansCells
  5. EBV-positive high-grade B-cell lymphoma with MYC and BCL6 rearrangements. Blood. 2022 07 28; 140(4):406. Craig A, Wen KW. PMID: 35900784.
    View in: PubMed Mentions: Fields:
    Translation:HumansCells
  6. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nat Biotechnol. 2021 12; 39(12):1537-1547. Kurtz DM, Soo J, Co Ting Keh L, Alig S, Chabon JJ, Sworder BJ, Schultz A, Jin MC, Scherer F, Garofalo A, Macaulay CW, Hamilton EG, Chen B, Olsen M, Schroers-Martin JG, Craig AFM, Moding EJ, Esfahani MS, Liu CL, Dührsen U, Hüttmann A, Casasnovas RO, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA. PMID: 34294911; PMCID: PMC8678141.
    View in: PubMed Mentions: 169 Fields:
    Translation:Humans
  7. Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2021 08 10; 39(23):2605-2616. Alig S, Macaulay CW, Kurtz DM, Dührsen U, Hüttmann A, Schmitz C, Jin MC, Sworder BJ, Garofalo A, Shahrokh Esfahani M, Nabet BY, Soo J, Scherer F, Craig AFM, Casasnovas O, Westin JR, Gaidano G, Rossi D, Roschewski M, Wilson WH, Meignan M, Diehn M, Alizadeh AA. PMID: 33909455; PMCID: PMC8331064.
    View in: PubMed Mentions: 45 Fields:
    Translation:Humans
  8. Liquid biopsy in lymphoma: Molecular methods and clinical applications. Cancer Treat Rev. 2020 Dec; 91:102106. Cirillo M, Craig AFM, Borchmann S, Kurtz DM. PMID: 33049623; PMCID: PMC8043056.
    View in: PubMed Mentions: 41 Fields:
    Translation:Humans
  9. Reply to J. Wang et al. J Clin Oncol. 2019 03 20; 37(9):755-757. Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas O, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA. PMID: 30753108.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  10. Response to "Added Points of Concern About Caring for Dying Patients". AMA J Ethics. 2018 11 01; 20(11):E1110-1112. Craig A, Dzeng E. PMID: 30499442.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  11. Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2018 10 01; 36(28):2845-2853. Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas RO, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA. PMID: 30125215; PMCID: PMC6161832.
    View in: PubMed Mentions: 249 Fields:
    Translation:Humans
  12. How Should Physicians Care for Dying Patients with Amyotrophic Lateral Sclerosis? AMA J Ethics. 2018 08 01; 20(8):E690-698. Craig A, Dzeng E. PMID: 30118418; PMCID: PMC6642362.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  13. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Sci Transl Med. 2016 11 09; 8(364):364ra155. Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, Maeda LS, Gupta NK, Levy R, Ohgami RS, Kunder CA, Diehn M, Alizadeh AA. PMID: 27831904; PMCID: PMC5490494.
    View in: PubMed Mentions: 255 Fields:
    Translation:HumansCells
  14. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis. 2011 Jan; 57(1):101-12. Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM, FHN Trial Group. PMID: 21184919; PMCID: PMC3073398.
    View in: PubMed Mentions: 37 Fields:
    Translation:Humans
  15. Attitudes toward physician-assisted suicide among physicians in Vermont. J Med Ethics. 2007 Jul; 33(7):400-3. Craig A, Cronin B, Eward W, Metz J, Murray L, Rose G, Suess E, Vergara ME. PMID: 17601867; PMCID: PMC2598148.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs